Huge negative momentum Sanofi-Aventis

Because of the huge loss of 6 percent since early this year, the share is one of the worst shares of the pharmaceutical sector. The average stock of the pharmaceutical sector yielded the this year a profit of 26 percent. Other underperforming shares are Hubei Minkang Pharmaceutical, Wize Pharma Inc and Oxis International .

Momentum pharmaceutical sector

For the average share in the sector around 351 times the earnings per share is paid. The sector trades now at 41,39 times the book value per share. The returns since 2007 are +467 percent and since 2012 +304 percent.

For this year the company, based inParijs revenue will be around 36,76 billion euros. This is according to the average of the analysts' estimates. This is slightly lower than 2019's revenue of 37,63 billion euros.

Historical revenues and results Sanofi-Aventis plus estimates 2020

Sodexo

The analysts expect for 2020 a net profit of 7,34 billion euros. The majority of the analysts expects for this year a profit per share of 5,81 euros. Based on this the price/earnings-ratio is 14,46.

Huge dividend Sanofi-Aventis

Per share the analysts expect a dividend of 3,19 euros per share. The dividend yield is then 3,8 percent. The average dividend yield of the pharmaceutical companies equals a moderate 0,2 percent.

Latest estimates around 103 euros

The most recent recommendations for the pharmaceutical company are from Goldman Sachs , JP Morgan and UBS .

Based on the current number of shares Sanofi-Aventis 's market capitalization equals 104,67 billion euros. The Sanofi-Aventis stock was the past 12 months quite unstable. Since last December the stock is 4 percent higher. This year the stock price moved between 68 and 96 euro.

Historical stock prices Sanofi-Aventis period 2007-2020

Click here for dividend Sanofi-Aventis. At 16.57 the stock trades 1,17 percent lower at 84,04 euros.

Analist.nl Nieuwsdienst: +31 084-0032-842
nieuws@analist.nl

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. Analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.